Vaccine Design and Testing – News and Features

Studying the evolutionary history of influenza viruses to quantitatively analyze how they evolved may help predict future strains and guide vaccine development.

Researchers have used artificial intelligence (AI) to identify promising target proteins with the potential for development into a vaccine against gonorrhea.

Drew Burch discusses how next-gen mRNA technology is one of the most valuable tools to combat and control disease outbreaks and why continued investment in this field is crucial for maintaining our pandemic preparedness.

A new study ties COVID-19 infection to an increased risk of a diagnosis of Guillain-Barre syndrome (GBS) within 6 weeks, while mRNA vaccination was linked to a decreased risk of the rare but serious autoimmune disease.

A study of infants and young children found those who acquired SARS-CoV-2 had a strong, sustained antibody response to the virus and high levels of inflammatory proteins in the nose but not in the blood.

What if a vaccine, given to patients just before or after arriving at the hospital, could protect them against lethal superbugs that lurk in health care settings? That’s the premise behind this experimental vaccine.

A new nasal vaccine, which uses an experimental liposome-based approach and is now in Phase 1 clinical trials, could provide long-term protection from Strep A.

A new study from the Norwegian Institute of Public Health (NIPH) found that women who do not menstruate, due to the use of hormonal contraception or menopause, reported unexpected vaginal bleeding after COVID-19 vaccination.

Dr. Katalin Karikó and Dr. Drew Weissman share the 2023 Nobel Prize in Medicine and Physiology for their research on nucleoside base modifications, which began in the 1990s and ultimately enabled the development of life-saving COVID-19 mRNA vaccines.

"PFAS is not just a problem for humans. It's a problem for species across the globe." Can humans act as an early warning system to understand their impact on other species?